Detailed information for compound 1590950

Basic information

Technical information
  • TDR Targets ID: 1590950
  • Name: 4-[4-(1-adamantyl)-5-(2-methoxyphenyl)-5H-1,2 ,4-oxadiazol-3-yl]-N-hydroxybenzeneamine oxid e
  • MW: 433.5 | Formula: C25H27N3O4
  • H donors: 0 H acceptors: 2 LogP: 5.63 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccccc1C1ON=C(N1C12CC3CC(C2)CC(C1)C3)c1ccc(cc1)[N+](=O)[O-]
  • InChi: 1S/C25H27N3O4/c1-31-22-5-3-2-4-21(22)24-27(25-13-16-10-17(14-25)12-18(11-16)15-25)23(26-32-24)19-6-8-20(9-7-19)28(29)30/h2-9,16-18,24H,10-15H2,1H3
  • InChiKey: UTOUMURSSRDWDC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[4-[4-(1-adamantyl)-5-(2-methoxyphenyl)-5H-1,2,4-oxadiazol-3-yl]phenyl]-N-oxidohydroxylamine
  • 4-(1-adamantyl)-5-(2-methoxyphenyl)-3-(4-nitrophenyl)-5H-1,2,4-oxadiazole
  • 4-[4-(1-adamantyl)-5-(2-methoxyphenyl)-5H-1,2,4-oxadiazol-3-yl]-N-hydroxy-benzeneamine oxide
  • N-[4-[4-(1-adamantyl)-5-(2-methoxyphenyl)-5H-1,2,4-oxadiazol-3-yl]phenyl]-N-oxido-hydroxylamine
  • AIDS146802
  • NSC674938
  • NCI60_026538
  • 4-(1-Adamantyl)-3-(4-(hydroxy(oxido)amino)phenyl)-5-(2-methoxyphenyl)-4,5-dihydro-1,2,4-oxadiazole
  • AIDS-146802

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis conserved hypothetical protein 0.0144 0.2523 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0144 0.2523 0.5
Plasmodium falciparum lysophospholipase, putative 0.0144 0.2523 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0144 0.2523 0.5
Plasmodium falciparum esterase, putative 0.0144 0.2523 1
Wolbachia endosymbiont of Brugia malayi aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0051 0 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.0422 1 1
Echinococcus granulosus fatty acid amide hydrolase 1 0.0422 1 1
Mycobacterium leprae POSSIBLE LYSOPHOSPHOLIPASE 0.0144 0.2523 1
Trichomonas vaginalis valacyclovir hydrolase, putative 0.0144 0.2523 0.5
Plasmodium falciparum lysophospholipase, putative 0.0144 0.2523 1
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0422 1 1
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0422 1 1
Treponema pallidum aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0051 0 0.5
Mycobacterium tuberculosis Possible lysophospholipase 0.0144 0.2523 1
Schistosoma mansoni fatty-acid amide hydrolase 0.0422 1 1
Loa Loa (eye worm) hypothetical protein 0.0422 1 1
Mycobacterium ulcerans hypothetical protein 0.0144 0.2523 1
Leishmania major monoglyceride lipase, putative 0.0144 0.2523 1
Trypanosoma brucei monoglyceride lipase, putative 0.0144 0.2523 1
Trichomonas vaginalis conserved hypothetical protein 0.0144 0.2523 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0144 0.2523 0.5
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0144 0.2523 0.5
Schistosoma mansoni amidase 0.0422 1 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0144 0.2523 0.5
Plasmodium falciparum lysophospholipase, putative 0.0144 0.2523 1
Plasmodium vivax PST-A protein 0.0144 0.2523 1
Chlamydia trachomatis glutamyl-tRNA(Gln) amidotransferase subunit A 0.0051 0 0.5
Trypanosoma cruzi monoglyceride lipase, putative 0.0144 0.2523 1
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0144 0.2523 0.5
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0144 0.2523 0.5
Trypanosoma brucei monoglyceride lipase, putative 0.0144 0.2523 1
Mycobacterium ulcerans lysophospholipase 0.0144 0.2523 1

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) -5.362 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.535 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.225 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.211 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.